CDMO 12.3 (-0.24%)
US05368M1062BiotechnologyBiotechnology

Avid Bioservices (CDMO) Stock Highlights

12.3 | -0.24%
2024-12-21 04:53:30
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Statistics

Range Today
12.29 12.34
Volume Today 1.06M
Range 1 Year
5.65 12.48
Volume 1 Year 332.9M
Range 3 Year
4.07 31.01
Volume 3 Year 676.71M
Range 10 Year
1.96 34.51
Volume 10 Year 1.32B

Highlights

Market Capitalization 784.1M (small)
Floating Shares 50.93M
Current Price 12.3
Price To Earnings -5.35
Price To Revenue 6.69
Price To Book 13.34
Earnings Per Share -2.29
Payout Ratio 0%

Performance

Latest -0.24%
1 Month +0.9%
3 Months -1.2%
6 Months +66.44%
1 Year +75.21%
3 Years -52.55%
5 Years +68.72%
10 Years +24.62%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.